Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies

被引：2
|
作者：
Ghobadi, Armin [1 ]
Landmann, Jack H. [1 ]
Carter, Alun [1 ]
Cooper, Matthew L. [1 ,3 ]
Selli, Mehmet Emrah [1 ]
Chang, Jufang [1 ]
Baker, Matthew [2 ]
Miller, Christopher A. [1 ]
Ferraro, Francesca [1 ]
Chen, David Y. [1 ]
Smith, Amanda M. [1 ]
LaValle, Taylor A. [1 ]
Duncavage, Eric J. [1 ]
Chou, Justin [4 ]
Tam, Victor [4 ]
Benoun, Joseph M. [4 ]
Nater, Jenny [4 ]
Scholler, Nathalie [4 ]
Milletti, Francesca [4 ]
Vezan, Remus [4 ]
Bot, Adrian [4 ]
Rossi, John M. [4 ]
Singh, Nathan [1 ]
机构：
[1] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
[3] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX USA
[4] Kite Gilead Co, Santa Monica, CA USA
来源：
BLOOD ADVANCES | 2022年 / 6卷 / 20期
关键词：
MUTATIONS; CANCER;
D O I：
10.1182/bloodadvances.2022007705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5634 / 5640
页数：7
相关论文
共 50 条
  • [1] Novel Chimeric Antigen Receptor T Cells for the Treatment of CD19-Negative Relapses Occurring after CD19-Targeted Immunotherapies
    Ruella, Marco
    Barrett, David
    Kenderian, Saad S.
    Shestova, Olga
    Hofmann, Ted J.
    Scholler, John
    Lacey, Simon F.
    Melenhorst, Jan J.
    Nazimuddin, Farzana
    Kalos, Michael
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    Gill, Saar I.
    BLOOD, 2014, 124 (21)
  • [2] CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
    Gambella, Massimiliano
    Carlomagno, Simona
    Raiola, Anna Maria
    Giannoni, Livia
    Ghiggi, Chiara
    Setti, Chiara
    Giordano, Chiara
    Luchetti, Silvia
    Serio, Alberto
    Bo, Alessandra
    Falco, Michela
    Della Chiesa, Mariella
    Angelucci, Emanuele
    Sivori, Simona
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia
    Barneh, F.
    Meulendijks, T.
    Wijnen, N.
    Koedijk, J.
    Ashtiani, M.
    Krippner-Heidenreich, A.
    Dunnebach, E.
    Nierkens, S.
    Kaspers, G.
    Heidenreich, O.
    KLINISCHE PADIATRIE, 2023, 235 (03): : 191 - 191
  • [4] A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia
    DasGupta, Ryan K.
    Marini, Bernard L.
    Rudoni, Joslyn
    Perissinotti, Anthony J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 453 - 467
  • [5] Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing
    Chen, Gregory M.
    Chen, Chia-Hui
    Perazzelli, Jessica
    Grupp, Stephan A.
    Barrett, David M.
    Tan, Kai
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (01) : 13 - 19
  • [6] CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B-cell lymphomas
    Watkins, Marcus P.
    Bartlett, Nancy L.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (07) : 601 - 611
  • [7] Generation of CD19-Targeted Chimeric Antigen Receptor T Cells
    Kiani, Jafar
    Naderi, Mahmood
    Torabi-Rahvar, Monireh
    Ranjbar, Azam
    Aghayan, Hamid-Reza
    Janzamin, Ehsan
    Ahmadbeigi, Naser
    ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (01) : 7 - 10
  • [8] CD19-targeted CAR T cells in refractory antisynthetase syndrome
    Mueller, Fabian
    Boeltz, Sebastian
    Knitza, Johannes
    Aigner, Michael
    Voelkl, Simon
    Kharboutli, Soraya
    Reimann, Hannah
    Taubmann, Jule
    Kretschmann, Sascha
    Roesler, Wolf
    Manger, Bernhard
    Wacker, Jochen
    Mougiakakos, Dimitrios
    Jabari, Samir
    Schroeder, Rolf
    Uder, Michael
    Roemer, Frank
    Kroenke, Gerhard
    Mackensen, Andreas
    Schett, Georg
    LANCET, 2023, 401 (10379): : 815 - 818
  • [9] CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
    Fry, Terry J.
    Shah, Nirali N.
    Orentas, Rimas J.
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    Ramakrishna, Sneha
    Wolters, Pamela
    Martin, Staci
    Delbrook, Cindy
    Yates, Bonnie
    Shalabi, Haneen
    Fountaine, Thomas J.
    Shern, Jack F.
    Majzner, Robbie G.
    Stroncek, David F.
    Sabatino, Marianna
    Feng, Yang
    Dimitrov, Dimiter S.
    Zhang, Ling
    Sang Nguyen
    Qin, Haiying
    Dropulic, Boro
    Lee, Daniel W.
    Mackall, Crystal L.
    NATURE MEDICINE, 2018, 24 (01) : 20 - +
  • [10] CD19-Targeted T Cells for Hematologic Malignancies Clinical Experience to Date
    Davila, Marco L.
    Sauter, Craig
    Brentjens, Renier
    CANCER JOURNAL, 2015, 21 (06): : 470 - 474
12345